Thermo Fisher Scientific (TMO) Introduces New Specialty Diagnostics Technologies to Help Clinicians Improve Patient Care
7/17/2012 10:11:01 AM
LOS ANGELES--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today highlighted its comprehensive range of specialty diagnostics products at the annual conference of the American Association for Clinical Chemistry (AACC). The company continued its focus on helping customers to improve productivity by introducing products that drive innovation in the clinical laboratory, from sample collection and storage to new immunoassays and quality controls. A number of new products are being showcased at Thermo Scientific booth 2215 during the Clinical Lab Expo at the AACC conference, being held at the Los Angeles Convention Center from July 17-19.
comments powered by